Published in Nat Immunol on January 09, 2005
Cytomegalovirus (CMV) MicroRNA Expression in Vivo and Immune Evasion Correlates | NCT00677482
Evolutionary struggles between NK cells and viruses. Nat Rev Immunol (2008) 3.79
Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev (2006) 3.30
Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev (2009) 2.75
DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors. J Exp Med (2008) 2.00
Modulation of natural killer cells by human cytomegalovirus. J Clin Virol (2008) 1.90
Quantitative temporal viromics: an approach to investigate host-pathogen interaction. Cell (2014) 1.58
Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture. J Gen Virol (2010) 1.51
Immune evasion of natural killer cells by viruses. Curr Opin Immunol (2008) 1.51
Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication. J Clin Invest (2010) 1.50
Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses. Cell Host Microbe (2013) 1.41
Natural killer cell function is intact after direct exposure to infectious hepatitis C virions. Hepatology (2009) 1.40
The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing. J Virol (2006) 1.35
The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR. J Virol (2012) 1.35
High-throughput sequence analysis of variants of human cytomegalovirus strains Towne and AD169. J Gen Virol (2009) 1.34
A novel human cytomegalovirus locus modulates cell type-specific outcomes of infection. PLoS Pathog (2011) 1.30
The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells. J Immunol (2007) 1.29
Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection. Immunity (2014) 1.24
Feeling manipulated: cytomegalovirus immune manipulation. Virol J (2009) 1.19
Stable isotope labeling by amino acids in cell culture and differential plasma membrane proteome quantitation identify new substrates for the MARCH9 transmembrane E3 ligase. Mol Cell Proteomics (2009) 1.19
Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells. Cancer Gene Ther (2008) 1.17
Structure of human cytomegalovirus UL141 binding to TRAIL-R2 reveals novel, non-canonical death receptor interactions. PLoS Pathog (2013) 1.17
Modulation of natural killer cell activity by viruses. Curr Opin Microbiol (2010) 1.16
Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor. Proc Natl Acad Sci U S A (2008) 1.13
Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors. J Virol (2006) 1.12
Molecular mechanisms of natural killer cell activation in response to cellular stress. Cell Death Differ (2013) 1.11
Cytomegalovirus destruction of focal adhesions revealed in a high-throughput Western blot analysis of cellular protein expression. J Virol (2007) 1.10
Deficient major histocompatibility complex-linked innate murine cytomegalovirus immunity in MA/My.L-H2b mice and viral downregulation of H-2k class I proteins. J Virol (2006) 1.10
A novel interface consisting of homologous immunoglobulin superfamily members with multiple functions. Cell Mol Immunol (2010) 1.10
NKG2D ligand MICA is retained in the cis-Golgi apparatus by human cytomegalovirus protein UL142. J Virol (2009) 1.09
Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation. PLoS Pathog (2014) 1.08
Identification of TRIM23 as a cofactor involved in the regulation of NF-kappaB by human cytomegalovirus. J Virol (2009) 1.07
Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112. J Gen Virol (2010) 1.06
Genomic and functional characteristics of human cytomegalovirus revealed by next-generation sequencing. Viruses (2014) 1.05
Open reading frames carried on UL/b' are implicated in shedding and horizontal transmission of rhesus cytomegalovirus in rhesus monkeys. J Virol (2011) 1.02
Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cells. Proc Natl Acad Sci U S A (2014) 0.99
The HCMV gH/gL/UL128-131 complex triggers the specific cellular activation required for efficient viral internalization into target monocytes. PLoS Pathog (2013) 0.95
Reevaluation of the coding potential and proteomic analysis of the BAC-derived rhesus cytomegalovirus strain 68-1. J Virol (2012) 0.94
HCMV pUL135 remodels the actin cytoskeleton to impair immune recognition of infected cells. Cell Host Microbe (2014) 0.93
Characterization of a highly glycosylated form of the human cytomegalovirus HLA class I homologue gpUL18. J Gen Virol (2005) 0.91
The Transcription and Translation Landscapes during Human Cytomegalovirus Infection Reveal Novel Host-Pathogen Interactions. PLoS Pathog (2015) 0.91
Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection. Curr HIV/AIDS Rep (2016) 0.87
Kaposi's sarcoma-associated herpesvirus ORF54/dUTPase downregulates a ligand for the NK activating receptor NKp44. J Virol (2012) 0.87
Interplay between human cytomegalovirus and intrinsic/innate host responses: a complex bidirectional relationship. Mediators Inflamm (2012) 0.87
Human Cytomegalovirus Latency: Approaching the Gordian Knot. Annu Rev Virol (2016) 0.86
Adenovirus vector delivery stimulates natural killer cell recognition. J Gen Virol (2007) 0.86
Human herpesvirus 7 u21 downregulates classical and nonclassical class I major histocompatibility complex molecules from the cell surface. J Virol (2010) 0.85
Human cytomegalovirus: taking the strain. Med Microbiol Immunol (2015) 0.84
A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men. J Infect Dis (2016) 0.84
An epistatic relationship between the viral protein kinase UL97 and the UL133-UL138 latency locus during the human cytomegalovirus lytic cycle. J Virol (2014) 0.84
A high-efficiency system of natural killer cell cloning. J Immunol Methods (2005) 0.84
Cytomegalovirus and tumors: two players for one goal-immune escape. Open Virol J (2011) 0.84
Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141. PLoS Pathog (2015) 0.83
Characterization of human cytomegalovirus UL145 and UL136 genes in low-passage clinical isolates from infected Chinese infants. Med Sci Monit (2011) 0.81
Limited dissemination and shedding of the UL128 complex-intact, UL/b'-defective rhesus cytomegalovirus strain 180.92. J Virol (2014) 0.81
Inhibition of the TRAIL death receptor by CMV reveals its importance in NK cell-mediated antiviral defense. PLoS Pathog (2014) 0.80
Modulation of Human Leukocyte Antigen-C by Human Cytomegalovirus Stimulates KIR2DS1 Recognition by Natural Killer Cells. Front Immunol (2017) 0.80
MCMV avoidance of recognition and control by NK cells. Semin Immunopathol (2014) 0.80
Human cytomegalovirus suppresses Fas expression and function. J Gen Virol (2014) 0.80
Genetic Stability of Bacterial Artificial Chromosome-Derived Human Cytomegalovirus during Culture In Vitro. J Virol (2016) 0.79
The structure of cytomegalovirus immune modulator UL141 highlights structural Ig-fold versatility for receptor binding. Acta Crystallogr D Biol Crystallogr (2014) 0.78
Critical roles of co-activation receptor DNAX accessory molecule-1 in natural killer cell immunity. Immunology (2015) 0.77
The susceptibility of primary cultured rhesus macaque kidney epithelial cells to rhesus cytomegalovirus strains. J Gen Virol (2016) 0.77
Self or nonself? That is the question: sensing of cytomegalovirus infection by innate immune receptors. Mamm Genome (2010) 0.77
Pseudorabies Virus US3 Protein Kinase Protects Infected Cells from NK Cell-Mediated Lysis via Increased Binding of the Inhibitory NK Cell Receptor CD300a. J Virol (2015) 0.76
Role of gB and pUS3 in Equine Herpesvirus 1 Transfer between Peripheral Blood Mononuclear Cells and Endothelial Cells: a Dynamic In Vitro Model. J Virol (2015) 0.76
Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation. Elife (2017) 0.75
The Clinical and Pathological Significance of Nectin-2 and DDX3 Expression in Pancreatic Ductal Adenocarcinomas. Dis Markers (2015) 0.75
Inflammatory monocytes and NK cells play a crucial role in DNAM-1-dependent control of cytomegalovirus infection. J Exp Med (2016) 0.75
Cytomegalovirus-Infected Cells Resist T Cell Mediated Killing in an HLA-Recognition Independent Manner. Front Microbiol (2016) 0.75
CD155, an onco-immunologic molecule in human tumors. Cancer Sci (2017) 0.75
A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A (1998) 24.58
Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med (1989) 7.52
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol (1996) 6.64
ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity (2001) 5.42
Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci U S A (2003) 5.21
Genetic content of wild-type human cytomegalovirus. J Gen Virol (2004) 3.58
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med (2003) 3.52
The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. J Gen Virol (2003) 3.48
Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science (2000) 3.20
A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation. Proc Natl Acad Sci U S A (1996) 3.14
Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol (1996) 2.68
Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci U S A (1999) 2.51
Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155). J Immunol (2004) 2.44
Nectins and nectin-like molecules: roles in cell adhesion, migration, and polarization. Cancer Sci (2003) 2.03
DNAM-1 and PVR regulate monocyte migration through endothelial junctions. J Exp Med (2004) 1.96
Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). Int Immunol (2004) 1.92
CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. J Exp Med (2003) 1.82
Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J Immunol (1999) 1.68
Amino acid residues on human poliovirus receptor involved in interaction with poliovirus. J Biol Chem (1994) 1.47
Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur J Immunol (2003) 1.46
Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med (1998) 1.43
In silico structural and functional analysis of the human cytomegalovirus (HHV5) genome. J Mol Biol (2001) 1.42
ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells. Eur J Immunol (2001) 1.37
UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc Natl Acad Sci U S A (2002) 1.36
Interaction of the poliovirus receptor CD155 with the dynein light chain Tctex-1 and its implication for poliovirus pathogenesis. J Biol Chem (2001) 1.27
Molecular characterization of the cellular receptor for poliovirus. Virology (1994) 1.23
Receptor (CD155)-dependent endocytosis of poliovirus and retrograde axonal transport of the endosome. J Virol (2004) 1.20
Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts. J Immunol (2000) 1.18
CD226 mediates platelet and megakaryocytic cell adhesion to vascular endothelial cells. J Biol Chem (2003) 1.18
How to recognize a foreign submarine. Immunol Rev (1997) 1.06
Human telomerase reverse transcriptase-immortalized MRC-5 and HCA2 human fibroblasts are fully permissive for human cytomegalovirus. J Gen Virol (2001) 1.02
Cytomegalovirus- and interferon-related effects on human endothelial cells. Cytomegalovirus infection reduces upregulation of HLA class II antigen expression after treatment with interferon-gamma. Hum Immunol (1992) 1.00
Ligand stimulation of CD155alpha inhibits cell adhesion and enhances cell migration in fibroblasts. Biochem Biophys Res Commun (2004) 0.94
The most abundantly transcribed human cytomegalovirus gene (beta 2.7) is non-essential for growth in vitro. J Gen Virol (2003) 0.92
Downregulation of the cellular adhesion molecule Thy-1 (CD90) by cytomegalovirus infection of human fibroblasts. J Gen Virol (2004) 0.89
NK cell-mediated lysis of autologous HCMV-infected skin fibroblasts is highly variable among NK cell clones and polyclonal NK cell lines. Clin Immunol (2002) 0.88
N glycosylation of the virus binding domain is not essential for function of the human poliovirus receptor. J Virol (1992) 0.85
Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat Med (2005) 8.01
Enrichment for living murine keratinocytes from the hair follicle bulge with the cell surface marker CD34. J Invest Dermatol (2003) 5.28
Genetic content of wild-type human cytomegalovirus. J Gen Virol (2004) 3.58
Colorimetric detection of loop-mediated isothermal amplification reaction by using hydroxy naphthol blue. Biotechniques (2009) 3.04
Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood (2002) 2.88
Topics in herpesvirus genomics and evolution. Virus Res (2006) 2.84
The genome of Epstein-Barr virus type 2 strain AG876. Virology (2006) 2.67
The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression. Genes Dev (2008) 2.48
p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence. Nat Cell Biol (2009) 2.46
Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death. Science (2007) 2.29
The family Parvoviridae. Arch Virol (2013) 2.12
A single autoimmune T cell receptor recognizes more than a million different peptides. J Biol Chem (2011) 2.06
Desmoglein 4 in hair follicle differentiation and epidermal adhesion: evidence from inherited hypotrichosis and acquired pemphigus vulgaris. Cell (2003) 2.06
The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity (2008) 2.04
Apparent competition, quantitative food webs, and the structure of phytophagous insect communities. Annu Rev Entomol (2006) 2.03
Specialization of mutualistic interaction networks decreases toward tropical latitudes. Curr Biol (2012) 1.96
Modulation of natural killer cells by human cytomegalovirus. J Clin Virol (2008) 1.90
Two novel spliced genes in human cytomegalovirus. J Gen Virol (2003) 1.87
Role of human cytomegalovirus UL131A in cell type-specific virus entry and release. J Gen Virol (2006) 1.83
High-resolution human cytomegalovirus transcriptome. Proc Natl Acad Sci U S A (2011) 1.67
Reduced tumor necrosis factor signaling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant. Arthritis Rheum (2005) 1.65
Genome sequences of three koi herpesvirus isolates representing the expanding distribution of an emerging disease threatening koi and common carp worldwide. J Virol (2007) 1.61
Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection. Proc Natl Acad Sci U S A (2011) 1.60
Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis. J Immunol (2005) 1.59
CD34 expression by hair follicle stem cells is required for skin tumor development in mice. Cancer Res (2007) 1.55
Koi herpesvirus represents a third cyprinid herpesvirus (CyHV-3) in the family Herpesviridae. J Gen Virol (2005) 1.54
Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture. J Gen Virol (2010) 1.51
Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication. J Clin Invest (2010) 1.50
Human cytomegalovirus labeled with green fluorescent protein for live analysis of intracellular particle movements. J Virol (2005) 1.49
Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur J Immunol (2003) 1.46
Human cytomegalovirus (HCMV) infection of endothelial cells promotes naive monocyte extravasation and transfer of productive virus to enhance hematogenous dissemination of HCMV. J Virol (2006) 1.44
Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin. Clin Cancer Res (2008) 1.44
Novel insect picorna-like virus identified in the brains of aggressive worker honeybees. J Virol (2004) 1.43
UL74 of human cytomegalovirus contributes to virus release by promoting secondary envelopment of virions. J Virol (2008) 1.42
Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses. Cell Host Microbe (2013) 1.41
Establishment of a poliovirus oral infection system in human poliovirus receptor-expressing transgenic mice that are deficient in alpha/beta interferon receptor. J Virol (2007) 1.40
HCMV spread and cell tropism are determined by distinct virus populations. PLoS Pathog (2011) 1.40
Sequences of complete human cytomegalovirus genomes from infected cell cultures and clinical specimens. J Gen Virol (2009) 1.39
UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc Natl Acad Sci U S A (2002) 1.36
Evolution and diversity in human herpes simplex virus genomes. J Virol (2013) 1.35
Kaposi's sarcoma-associated herpesvirus immune modulation: an overview. J Gen Virol (2006) 1.34
High-throughput sequence analysis of variants of human cytomegalovirus strains Towne and AD169. J Gen Virol (2009) 1.34
Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function. Biotechniques (2008) 1.33
The tumor suppressor protein TSLC1 is involved in cell-cell adhesion. J Biol Chem (2002) 1.33
The role of the 3' untranslated region in post-transcriptional regulation of protein expression in mammalian cells. RNA Biol (2012) 1.31
Complete genome sequences of elephant endotheliotropic herpesviruses 1A and 1B determined directly from fatal cases. J Virol (2013) 1.31
The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells. J Immunol (2007) 1.29
Hepatitis C virus induces E6AP-dependent degradation of the retinoblastoma protein. PLoS Pathog (2007) 1.29
Endoplasmic reticulum stress and apoptosis. Cell Mol Biol Lett (2006) 1.24
Viral evasion of T cell immunity: ancient mechanisms offering new applications. Curr Opin Immunol (2010) 1.24
Immunofluorescence analysis of poliovirus receptor expression in Peyer's patches of humans, primates, and CD155 transgenic mice: implications for poliovirus infection. J Infect Dis (2002) 1.23
Analysis of the first complete genome sequence of an Old World monkey adenovirus reveals a lineage distinct from the six human adenovirus species. J Gen Virol (2004) 1.22
Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants. Blood (2003) 1.22
Do differences in food web structure between organic and conventional farms affect the ecosystem service of pest control? Ecol Lett (2009) 1.21
p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes. J Clin Invest (2013) 1.21
Receptor (CD155)-dependent endocytosis of poliovirus and retrograde axonal transport of the endosome. J Virol (2004) 1.20
Stability of human cytomegalovirus genotypes in persistently infected renal transplant recipients. J Med Virol (2005) 1.20
TL1A both promotes and protects from renal inflammation and injury. J Am Soc Nephrol (2008) 1.18
Inhibition of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein. J Virol (2006) 1.16
Anterior gradient 2: a novel player in tumor cell biology. Cancer Lett (2011) 1.16
The TNF-like protein 1A-death receptor 3 pathway promotes macrophage foam cell formation in vitro. J Immunol (2010) 1.16
Proliferation and interleukin 5 production by CD8hi CD57+ T cells. Eur J Immunol (2008) 1.16
A perspective on murine keratinocyte stem cells as targets of chemically induced skin cancer. Mol Carcinog (2007) 1.15
Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein. J Virol (2003) 1.15
Positive feedback between p53 and TRF2 during telomere-damage signalling and cellular senescence. Nat Cell Biol (2010) 1.14
New ELISA technique for analysis of p53 protein/DNA binding properties. J Immunol Methods (2002) 1.14
Human cytomegalovirus entry into dendritic cells occurs via a macropinocytosis-like pathway in a pH-independent and cholesterol-dependent manner. PLoS One (2012) 1.14
Peptide length determines the outcome of TCR/peptide-MHCI engagement. Blood (2012) 1.13
hDectin-1 is involved in uptake and cross-presentation of cellular antigens. Blood (2007) 1.13
The Yin and Yang of bone morphogenetic proteins in cancer. Cytokine Growth Factor Rev (2010) 1.13